APIs Will Be Covered in Pharmaceutical Tariff
A White House official said that active pharmaceutical ingredients imported into the U.S. for medicine manufacturing will be covered by the Section 232 tariffs on branded pharmaceuticals.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
The details of the action have not been published in the Federal Register, nor is there a date they will start. The president had once said Oct. 1, but Commerce Secretary Howard Lutnick said companies were being given time to negotiate (see 2510020033) on whether they will sell patented drugs in the U.S. at the same price they sell them in Europe or Canada.
Some members of Congress have argued that the greater national security threat is generic drugs, which are the vast majority of prescriptions in America, but a small slice of spending. India is a dominant producer of generic drugs, but China is the source of some vitamins and medicines, and it supplies Indian manufacturers with many active pharmaceutical ingredients.